HomeSearchCritical Reviews in Oncology/Hematology

Critical Reviews in Oncology/Hematology

Elsevier Ireland Ltd · Ireland

ISSN1040-8428eISSN1879-0461
SJR Q1WOS SCIEScopus / SJR
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q1
SJR · Scopus
Top 25% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
1.977
H-Indexi
178
SNIPi
1.403
Total Worksi
5,818
Total Citationsi
206,257
2yr Mean Citednessi
4.43
Open Impact Factor alternative

Aims & Scope

Subject areas: Hematology; Oncology; Geriatrics and Gerontology.

General Information

Country / RegionIreland
Primary LanguageEnglish
1st Year Published
FrequencyTwelve No. A Year
StatusActive
Total Publications5,818
Publisher OrgElsevier BV
Visit Journal Website

Submission Info

Publishing ModelHybrid
Peer Review
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Hybrid journal — subscription model available.

Think.Check.Submit Compliance

6/11 · 55%
Do you know the journal / publisher?
Elsevier Ireland Ltd
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1040-8428 / 1879-0461
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
202
9k
2019
240
9.4k
2020
246
6.6k
2021
211
5.8k
2022
212
3.4k
2023
280
3.4k
2024
417
2.4k
2025
385
302
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Geriatrics and GerontologyQ1
HematologyQ1
OncologyQ1

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyGeriatrics and GerontologyOncology

Research Topics (OpenAlex)

Lung Cancer Treatments and MutationsDiverse Scientific and Economic StudiesCancer Immunotherapy and BiomarkersHuman auditory perception and evaluationEducational Robotics and Engineering

Frequently asked questions about Critical Reviews in Oncology/Hematology

Is Critical Reviews in Oncology/Hematology a predatory journal?

PubScope has no integrity flags on record for Critical Reviews in Oncology/Hematology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Critical Reviews in Oncology/Hematology?

Critical Reviews in Oncology/Hematology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.43.

Is Critical Reviews in Oncology/Hematology indexed in Scopus and Web of Science?

Critical Reviews in Oncology/Hematology is indexed in Web of Science, Scopus.

What is the aims and scope of Critical Reviews in Oncology/Hematology?

Subject areas: Hematology; Oncology; Geriatrics and Gerontology.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref